
Sign up to save your podcasts
Or


This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.
By Moira Gunn4.1
2929 ratings
This week on BioTech Nation, Luminary Therapeutics CEO Jeff Liter shares how his team is working to make advanced cell therapy easier to access and more affordable. Instead of using each patient’s own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.

21,968 Listeners

43,831 Listeners

32,011 Listeners

30,711 Listeners

43,594 Listeners

707 Listeners

6,407 Listeners

30,212 Listeners

125 Listeners

320 Listeners

9,935 Listeners

34 Listeners

18 Listeners

48 Listeners

138 Listeners